BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19513634)

  • 1. Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway.
    Michaelson JS; Burkly LC
    Results Probl Cell Differ; 2009; 49():145-60. PubMed ID: 19513634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TWEAK and Fn14: new molecular targets for cancer therapy?
    Winkles JA; Tran NL; Berens ME
    Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
    Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
    Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway.
    Wang D; Fung JN; Tuo Y; Hu L; Chen C
    Cancer Lett; 2010 Aug; 294(1):91-100. PubMed ID: 20189297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
    Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
    Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
    Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
    Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TWEAK promotes ovarian cancer cell metastasis via NF-kappaB pathway activation and VEGF expression.
    Dai L; Gu L; Ding C; Qiu L; Di W
    Cancer Lett; 2009 Oct; 283(2):159-67. PubMed ID: 19398263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome.
    Huang M; Narita S; Tsuchiya N; Ma Z; Numakura K; Obara T; Tsuruta H; Saito M; Inoue T; Horikawa Y; Satoh S; Habuchi T
    Carcinogenesis; 2011 Nov; 32(11):1589-96. PubMed ID: 21828059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases.
    Yepes M; Winkles JA
    Drug News Perspect; 2006 Dec; 19(10):589-95. PubMed ID: 17299600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.
    Mustonen E; Säkkinen H; Tokola H; Isopoussu E; Aro J; Leskinen H; Ruskoaho H; Rysä J
    Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa).
    Shui Y; Guan ZB; Zhang SQ
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):396-402. PubMed ID: 18817982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tweak induces mammary epithelial branching morphogenesis.
    Michaelson JS; Cho S; Browning B; Zheng TS; Lincecum JM; Wang MZ; Hsu YM; Burkly LC
    Oncogene; 2005 Apr; 24(16):2613-24. PubMed ID: 15735761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
    Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N
    Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.
    Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis.
    Kataria NG; Bartold PM; Dharmapatni AA; Atkins GJ; Holding CA; Haynes DR
    J Periodontal Res; 2010 Aug; 45(4):564-73. PubMed ID: 20546112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    Clin Exp Immunol; 2006 Dec; 146(3):540-9. PubMed ID: 17100776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses.
    Burkly LC; Michaelson JS; Zheng TS
    Immunol Rev; 2011 Nov; 244(1):99-114. PubMed ID: 22017434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TWEAK/Fn14 axis: the current paradigm of tissue injury-inducible function in the midst of complexities.
    Burkly LC
    Semin Immunol; 2014 Jun; 26(3):229-36. PubMed ID: 24636536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis.
    Pettersen I; Baryawno N; Abel F; Bakkelund WH; Zykova SN; Winberg JO; Moens U; Rasmuson A; Kogner P; Johnsen JI; Sveinbjörnsson B
    Int J Oncol; 2013 Apr; 42(4):1239-48. PubMed ID: 23443741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.
    Kamijo S; Nakajima A; Kamata K; Kurosawa H; Yagita H; Okumura K
    Rheumatology (Oxford); 2008 Apr; 47(4):442-50. PubMed ID: 18310134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.